A RETROSPECTIVE ANALYSIS OF PROGNOSTIC FACTORS FOR SURVIVAL IN PATIENTS WITH HIGH-RISK NEUROBLASTOMA AFTER 1ST RECURRENCE: A REPORT FROM THE JAPAN NEUROBLASTOMA STUDY GROUP

被引：0
|
作者：
Hara, Junichi [1 ]
Takimoto, Tetsuya [2 ]
Shichino, Hiroyuki [3 ]
Matsumoto, Kimikazu [4 ]
Kuroda, Tatsuo [5 ]
Hishiki, Tomoro [6 ]
Soejima, Toshinori [7 ]
Hashii, Yoshiko [8 ]
Mori, Tetsuya [9 ]
Ikeda, Hitoshi [10 ]
机构：
[1] Osaka City Gen Hosp, Osaka, Japan
[2] Natl Ctr Child Hlth & Dev, Tokyo, Japan
[3] Nihon Univ, Tokyo, Japan
[4] Japanese Red Cross Nagoya First Hosp, Nagoya, Aichi, Japan
[5] Keio Univ, Tokyo, Japan
[6] Chiba Univ, Grad Sch Med, Chiba, Japan
[7] Hyogo Prefectural Canc Ctr, Akashi, Hyogo, Japan
[8] Osaka Univ, Grad Sch Med, Suita, Osaka, Japan
[9] Natl Ctr Child Hlth & Dev, Tokyo, Japan
[10] Dokkyo Med Univ, Koshigaya Hosp, Koshigaya, Japan
来源：
PEDIATRIC BLOOD & CANCER | 2012年 / 59卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1059 / 1059
页数：1
相关论文
共 50 条
  • [1] Predicting Response to Chemotherapy in Patients With Newly Diagnosed High-Risk Neuroblastoma: A Report From the International Neuroblastoma Risk Group
    Mayampurath, Anoop
    Ramesh, Siddhi
    Michael, Diana
    Liu, Liu
    Feinberg, Nicholas
    Granger, Meaghan
    Naranjo, Arlene
    Cohn, Susan L.
    Volchenboum, Samuel L.
    Applebaum, Mark A.
    JCO CLINICAL CANCER INFORMATICS, 2021, 5 : 1181 - 1188
  • [2] Significance of Molecular-Biological Prognostic Factors in High-Risk Neuroblastoma Patients
    Shorikov, E.
    Druy, A.
    Zaychikov, A.
    Chusovitin, D.
    Popova, T.
    Lemesheva, O.
    Vyatkin, I.
    Tuponogov, S.
    Tsaur, G.
    Popov, A.
    Saveliev, L.
    Fechina, L.
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S203 - S203
  • [3] High-Risk Neuroblastoma with Recurrence 28 Years after Initial Diagnosis: A Case Report
    Kritselis, M.
    Boxerman, J.
    DeNardo, B.
    Mistry, H.
    Perez-Atayde, A.
    Punsoni, M.
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2023, 82 (06): : 559 - 560
  • [4] MOLECULAR PROFILING INCLUDING GENOMIC ABERRATIONS CAN REVEAL ULTRA HIGH-RISK GROUP IN THE JAPAN NEUROBLASTOMA STUDY GROUP'S CLINICAL TRIAL FOR HIGH-RISK NEUROBLASTOMA
    Matsumoto, K.
    Ohira, M.
    Kamijo, T.
    Shichino, H.
    Kuroda, T.
    Hishiki, T.
    Soejima, T.
    Kaneko, T.
    Nakazawa, A.
    Takimoto, T.
    Fukushima, T.
    Hara, J.
    Kaneko, M.
    Ikeda, H.
    Tajiri, T.
    Nakagawara, A.
    PEDIATRIC BLOOD & CANCER, 2015, 62 : S225 - S225
  • [5] A nomogram of clinical and biologic factors to predict survival in children newly diagnosed with high-risk neuroblastoma: An International Neuroblastoma Risk Group project
    Moreno, Lucas
    Guo, Dongjing
    Irwin, Meredith S.
    Berthold, Frank
    Hogarty, Michael
    Kamijo, Takehiko
    Morgenstern, Daniel
    Pasqualini, Claudia
    Ash, Shifra
    Potschger, Ulrike
    Ladenstein, Ruth
    Valteau-Couanet, Dominique
    Cohn, Susan L.
    Pearson, Andrew D. J.
    London, Wendy B.
    PEDIATRIC BLOOD & CANCER, 2021, 68 (03)
  • [6] Overall survival and event free survival in patients with high-risk neuroblastoma after targeted therapy
    Mazankova, D.
    Mazanek, P.
    Maskova, V.
    Tinka, P.
    Kyr, M.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2022, 44 (06) : 1546 - 1546
  • [7] High-risk neuroblastoma with recurrence 28 years after initial diagnosis-A case report
    Kritselis, M.
    Punsoni, M.
    Mistry, H.
    Boxerman, J.
    BRAIN PATHOLOGY, 2023, 33
  • [8] Analysis of high-risk prognostic factors in children with neuroblastoma: A systematic review and meta-analysis
    Chen, Rong
    Lou, Xu-yan
    Ren, Chang-cheng
    ASIAN JOURNAL OF SURGERY, 2024, 47 (11) : 4896 - 4898
  • [9] Clinical and Biologic Features Predictive of Survival After Relapse of Neuroblastoma: A Report From the International Neuroblastoma Risk Group Project
    London, Wendy B.
    Castel, Victoria
    Monclair, Tom
    Ambros, Peter F.
    Pearson, Andrew D. J.
    Cohn, Susan L.
    Berthold, Frank
    Nakagawara, Akira
    Ladenstein, Ruth L.
    Iehara, Tomoko
    Matthay, Katherine K.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (24) : 3286 - 3292
  • [10] Frequency and Prognostic Impact of ALK Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1)
    Bellini, Angela
    Poetschger, Ulrike
    Bernard, Virginie
    Lapouble, Eve
    Baulande, Sylvain
    Ambros, Peter F.
    Auger, Nathalie
    Beiske, Klaus
    Bernkopf, Marie
    Betts, David R.
    Bhalshankar, Jaydutt
    Bown, Nick
    de Preter, Katleen
    Clement, Nathalie
    Combaret, Valerie
    de Mora, Jaime Font
    George, Sally L.
    Jimenez, Irene
    Jeison, Marta
    Marques, Barbara
    Martinsson, Tommy
    Mazzocco, Katia
    Morini, Martina
    Muehlethaler-Mottet, Annick
    Noguera, Rosa
    Pierron, Gaelle
    Rossing, Maria
    Taschner-Mandl, Sabine
    Van Roy, Nadine
    Vicha, Ales
    Chesler, Louis
    Balwierz, Walentyna
    Castel, Victoria
    Elliott, Martin
    Kogner, Per
    Laureys, Genevieve
    Luksch, Roberto
    Malis, Josef
    Popovic-Beck, Maja
    Ash, Shifra
    Delattre, Olivier
    Valteau-Couanet, Dominique
    Tweddle, Deborah A.
    Ladenstein, Ruth
    Schleiermacher, Gudrun
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (30) : 3377 - +
12345